date:Jul 19, 2012
agnosis of dementia or other psychological or neurological diseases which may be responsible for the impairmentwere admissible.
Any extrapolation, for instance from patients with dementia, must be explained including any medication contraindications, and would be considered case-by-case by the panel.
Specific advice was also issued for alertness, attention, memory, mood, stress, anxiety, vision and sleep.
EFSA also issued guidance on 'physical claims'. Look here for coverage of that tomorrow.